Perioperative Hyperoxia: A Summary of the Evidence - Mark Robitaille, MD
Upon completion of this activity, the learner will be able to
- Define hyperoxia as a supraphysiologic and iatrogenic condition that is the result of positive pressure ventilation or supplemental oxygen administration.
- Realize the important physiologic changes that result from hyperoxia: decreased cardiac output, decreased pulmonary artery pressure, increased systemic vascular resistance.
- Identify colorectal surgery patients as one group that may benefit from hyperoxia in the form of decreased incidence of surgical site infection.
Mark Robitaille, MD
Michael Perouansky, MD
It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during the educational activity. For this educational activity all conflicts of interests have been resolved and detailed disclosures are listed below:
Mark Robitaille, MD: No relevant relationships to disclose in regard to this activity.
Michael Perouansky, MD: No relevant relationships to disclose in regard to this activity.
Brandon Russell: No relevant relationships to disclose in regard to this activity.
Jessica Carlucci-Jenkins, BA: No relevant relationships to disclose in regard to this activity.
Kim Sprecker: No relevant relationships to disclose in regard to this activity.
* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Disclosure of Unlabeled Use: The University of Wisconsin–Madison ICEP advises the participant that this continuing medical education activity does NOT contain reference(s) to unlabeled or unapproved uses of drugs or devices
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 University of Wisconsin–Madison Continuing Education Hours